OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ANRE57

Analabs Resources Bhd

Commodity ChemicalsVerified

Analabs Resources Bhd maintains a debt-to-equity ratio of 0.42, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 0.39, suggesting that its short-term assets may not fully cover its short-term liabilities. The company's free cash flow of 7.9 million MYR indicates a positive cash flow from operations after capital expenditures, supporting its operational flexibility. In terms of profitability, the company's return on equity (ROE) is 1.83%, and its return on assets (ROA) is 1.2%, both of which are below the typical thresholds for strong performance in the commodity chemicals industry. The operating margin, calculated as operating income divided by revenue, is 40.4%, which is relatively high compared to industry norms, suggesting efficient cost management. The company's revenue is primarily concentrated in its core chemical manufacturing operations, with no significant geographic diversification disclosed in the available data. This concentration may expose the company to regional economic fluctuations and regulatory changes affecting the chemical industry in its primary market. The company's growth trajectory is not explicitly detailed in the available data, but its current revenue of 29.43 million MYR and net income of 7.92 million MYR suggest a stable, though not rapidly growing, business. The capital expenditure of -378,000 MYR indicates a reduction in investment in new assets, which may signal a focus on maintaining existing operations rather than expanding. The risk assessment highlights a medium liquidity risk and a low dilution risk, with the key flag being that net cash is negative after subtracting total debt. The company's dilution potential is low, as the number of basic and diluted shares outstanding is the same, indicating no imminent threat from share dilution. Recent events and filings do not provide specific details on new projects or strategic initiatives, but the company's financial performance and risk profile suggest a stable, if not particularly dynamic, business environment.

30-day price · ANRE+0.09 (+5.4%)
Low$1.62High$1.77Close$1.77As of21 May, 00:00 UTC
Profile
CompanyAnalabs Resources Bhd
TickerANRE.KL
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Analabs Resources Bhd is a chemical manufacturing company operating in the commodity chemicals industry, primarily generating revenue through the production and sale of chemical products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Analabs Resources Bhd maintains a debt-to-equity ratio of 0.42, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 0.39, suggesting that its short-term assets may not fully cover its short-term liabilities. The company's free cash flow of 7.9 million MYR indicates a positive cash flow from operations after capital expenditures, supporting its operational flexibility. In terms of profitability, the company's return on equity (ROE) is 1.83%, and its return on assets (ROA) is 1.2%, both of which are below the typical thresholds for strong performance in the commodity chemicals industry. The operating margin, calculated as operating income divided by revenue, is 40.4%, which is relatively high compared to industry norms, suggesting efficient cost management. The company's revenue is primarily concentrated in its core chemical manufacturing operations, with no significant geographic diversification disclosed in the available data. This concentration may expose the company to regional economic fluctuations and regulatory changes affecting the chemical industry in its primary market. The company's growth trajectory is not explicitly detailed in the available data, but its current revenue of 29.43 million MYR and net income of 7.92 million MYR suggest a stable, though not rapidly growing, business. The capital expenditure of -378,000 MYR indicates a reduction in investment in new assets, which may signal a focus on maintaining existing operations rather than expanding. The risk assessment highlights a medium liquidity risk and a low dilution risk, with the key flag being that net cash is negative after subtracting total debt. The company's dilution potential is low, as the number of basic and diluted shares outstanding is the same, indicating no imminent threat from share dilution. Recent events and filings do not provide specific details on new projects or strategic initiatives, but the company's financial performance and risk profile suggest a stable, if not particularly dynamic, business environment.
Key takeaways
  • The company maintains a conservative capital structure with a debt-to-equity ratio of 0.42.
  • The operating margin of 40.4% is relatively high, indicating efficient cost management.
  • The company's liquidity position is characterized as medium risk, with a current ratio of 0.39.
  • The company's free cash flow of 7.9 million MYR supports operational flexibility.
  • The company's growth trajectory is not explicitly detailed, but its financial performance suggests a stable business.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$29.4M
Gross profit$9.8M
Operating income$11.9M
Net income$7.9M
R&D
SG&A
D&A
SBC
Operating cash flow$23.9M
CapEx-$378.0k
Free cash flow$7.9M
Total assets$659.6M
Total liabilities$227.3M
Total equity$432.3M
Cash & equivalents$23.4M
Long-term debt$179.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$117.5M$21.4M$16.4M$20.8M
FY-3$117.6M$41.7M$29.5M$37.6M
FY-2$133.4M$38.2M$28.3M$31.1M
FY-1$152.5M$42.4M$27.7M$30.2M
FY0$138.3M$56.9M$37.9M$40.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$401.5M$281.5M$14.8M
FY-3$445.0M$322.2M$22.0M
FY-2$518.3M$346.5M$17.0M
FY-1$659.6M$432.3M$23.4M
FY0$755.5M$476.4M$28.5M
PeriodOCFCapExFCFSBC
FY-4$11.1M-$340.0k$20.8M
FY-3$7.4M-$2.3M$37.6M
FY-2$15.8M-$1.0M$31.1M
FY-1$23.9M-$378.0k$30.2M
FY0$40.7M-$334.0k$40.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$29.4M$11.9M$7.9M$7.9M
FQ-6$32.2M$10.1M$5.6M$7.4M
FQ-5$36.6M$23.0M$17.4M$18.8M
FQ-4$26.5M$3.8M$1.7M$2.6M
FQ-3$43.0M$20.0M$13.2M$15.9M
FQ-2$21.7M$1.7M$1.1M$1.8M
FQ-1$34.7M$23.7M$12.6M$12.8M
FQ0$24.6M$19.9M$13.0M$15.4M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$659.6M$432.3M$23.4M
FQ-6$689.4M$456.2M$20.2M
FQ-5$747.7M$485.8M$26.9M
FQ-4$756.0M$476.7M$17.5M
FQ-3$755.5M$476.4M$28.5M
FQ-2$749.2M$447.6M$23.3M
FQ-1$794.8M$489.2M$27.2M
FQ0$899.1M$600.1M$28.0M
PeriodOCFCapExFCFSBC
FQ-7$23.9M-$378.0k$7.9M
FQ-6$5.1M-$39.0k$7.4M
FQ-5$15.5M-$129.0k$18.8M
FQ-4$1.1M-$612.0k$2.6M
FQ-3$40.7M-$334.0k$15.9M
FQ-2-$5.8M-$97.0k$1.8M
FQ-1-$6.1M-$1.2M$12.8M
FQ0$7.6M-$1.1M$15.4M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$432.3M
Net cash-$156.2M
Current ratio0.4
Debt/Equity0.4
ROA1.2%
ROE1.8%
Cash conversion3.0%
CapEx/Revenue-1.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricANREActivity
Op margin40.4%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin26.9%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin33.2%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-1.3%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity42.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Last actual EPS0.08 MYR
Last actual revenue54,651,000 MYR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 01:16 UTC#7107139c
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 09:01 UTCJob: b93e4a05